Reduced cancer progression, risk One paper, published in the affiliated Journal of Clinical Oncology in late May, looked at more than 10,000 medical records and found GLP-1 use among cancer patients was linked to dramatically reduced disease progression across multiple types of tumors, including some forms not largely linked to obesity
A well-established clinical example is PEGylated liposomal doxorubicin (PLD
L-carnitine (2 grams per day) has been reported to resolve Hashimotos-related fatigue and has also been found to support antioxidant activities in the body, while acetyl-L-carnitine has unique brain-supportive properties and has been shown to help to reduce mental fatigue (and improve cognitive function) in various studies (bye bye brain fog!)
Eradicates bacteria, fungi, and viruses
PMID: 32276632 2 Primary carnitine deficiency in a 57-year-old patient with recurrent exertional rhabdomyolysis
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses